PDB 5lz9

PDB Information

PDB5LZ9
MethodX-RAY DIFFRACTION
Host OrganismEscherichia coli BL21(DE3)
Gene SourceHomo sapiens
Primary Citation
Fragment-Based Approach to the Development of an Orally Bioavailable Lactam Inhibitor of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2).
Woolford, A.J., Day, P.J., Beneton, V., Berdini, V., Coyle, J.E., Dudit, Y., Grondin, P., Huet, P., Lee, L.Y., Manas, E.S., McMenamin, R.L., Murray, C.W., Page, L.W., Patel, V.K., Potvain, F., Rich, S.J., Sang, Y., Somers, D.O., Trottet, L., Wan, Z., Zhang, X.
J. Med. Chem.
HeaderHydrolase
Released2016-09-29
Resolution2.060
CATH Insert Date08 Jan, 2017

PDB Images (3)

PDB Prints

PDB Chains (1)

Chain ID Date inserted into CATH CATH Status
A 09 Jan, 2017 Chopped

CATH Domains (1)

Domain ID Date inserted into CATH Superfamily CATH Status
5lz9A00 19 Jan, 2017 3.40.50.1820 Assigned

UniProtKB Entries (1)

Accession Gene ID Taxon Description
Q13093 PAFA_HUMAN Homo sapiens Platelet-activating factor acetylhydrolase
CATH-Gene3D is a Global Biodata Core Resource Learn more...